Literature DB >> 16405611

Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus.

R Shichinohe1, A Shibaki, W Nishie, Y Tateishi, H Shimizu.   

Abstract

Oral lichen planus (LP) is a severe, painful form of LP, and is often resistant to topical corticosteroid therapy. Recently, open trials demonstrated that topical tacrolimus therapy was effective for the treatment of chronic erosive oral LP. We report two cases with severe recalcitrant erosive oral LP, who dramatically benefited from topical tacrolimus therapy. In case 1, a 64-year-old man presented with a 5-month history of painful erosions on his entire lower lip and buccal mucosa. Physical and histological examination confirmed a diagnosis of LP. He experienced rapid relief from pain and a dramatic improvement was obtained within 5 weeks of topical tacrolimus treatment. No significant irritation was observed and blood tacrolimus level was kept within a safe level (2.5 ng/mL). In case 2, a 68-year-old man developed painful erosions on his right lower lip and buccal mucosa 2 months before his arrival at our hospital. Histopathological analysis confirmed a diagnosis of oral LP. He experienced a rapid dramatic improvement of both lesions within 4 weeks of the start of tacrolimus application. No significant irritation or recurrence was observed. Thus, topical tacrolimus is suggested as a well-tolerated, effective therapy for oral LP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405611     DOI: 10.1111/j.1468-3083.2005.01338.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

Review 1.  Efficacy of topical non-steroidal immunomodulators in the treatment of oral lichen planus: a systematic review and meta-analysis.

Authors:  Eduardo Liberato da Silva; Taiane Berguemaier de Lima; Pantelis Varvaki Rados; Fernanda Visioli
Journal:  Clin Oral Investig       Date:  2021-08-03       Impact factor: 3.573

2.  Oral lichen planus treated with tacrolimus 0.1%.

Authors:  João Paulo Marinho Resende; Maria das Graças Afonso Miranda Chaves; Fernando Monteiro Aarestrup; Beatriz Vieira Aarestrup; Sergio Olate; Henrique Duque Netto
Journal:  Int J Clin Exp Med       Date:  2013-10-25

3.  The effect of pimecrolimus cream 1% compared with triamcinolone acetonide paste in treatment of atrophic-erosive oral lichen planus.

Authors:  Atessa Pakfetrat; Zahra Delavarian; Farnaz Falaki; Mahboubeh Khorashadizadeh; Mina Saba
Journal:  Iran J Otorhinolaryngol       Date:  2015-03

Review 4.  Candida is a protractive factor of chronic oral ulcers among usual outpatients.

Authors:  Haruhiko Terai; Takaaki Ueno; Yoshifumi Suwa; Michi Omori; Kayoko Yamamoto; Shin Kasuya
Journal:  Jpn Dent Sci Rev       Date:  2018-01-12

5.  The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report.

Authors:  Mayu Morita; Seiji Asoda; Kazuyuki Tsunoda; Tomoya Soma; Taneaki Nakagawa; Masayori Shirakawa; Hirofumi Shoji; Hisao Yagishita; Takeji Nishikawa; Hiromasa Kawana
Journal:  Odontology       Date:  2016-07-01       Impact factor: 2.634

Review 6.  Oral lichen planus: clinical and histopathological considerations.

Authors:  Fernando Augusto Cervantes Garcia de Sousa; Luiz Eduardo Blumer Rosa
Journal:  Braz J Otorhinolaryngol       Date:  2008 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.